High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
Clinical trial NCT00801216 · COMPLETED
Trial details
- NCT number
- NCT00801216
- Sponsor
- Andrés José Maria Ferreri
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2013-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.